Hemoperfusion Therapy’s Efficiency in Reducing Serum IL-6 Levels and Disease Severity in COVID-19 Patients

Hemoperfusion Therapy’s Efficiency in Reducing Serum IL-6 Levels and Disease Severity in COVID-19 Patients

Background: Interleukin (IL)-6, one of the inflammatory mediators involved in severe cases of coronavirus disease-19 (COVID-19), has been implicated in the pathogenesis of this disease. Extracorporeal blood purification has been suggested as one of the therapeutic strategies for COVID-19 patients, d...

Full description

Bibliographic Details
Main Authors: Mohammad Bakhshivand, Farid Ghorbaninezhad, Somaye Mirzayi, Nima Hemmat, Khalil Ansarin, Mohammad Reza Ardalan, Ali Taghizadieh, Maseoud Nazemiyeh, Mahdi Jafarlou, Farid Rashidi, Armin Sadeghi, Arsalan Yazdchi, Saeid Safiri, Haleh Mikaeili
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2022-12-01
Series:ImmunoAnalysis
Subjects:
covid-19
severe respiratory failure
acute respiratory distress syndrome
cytokine storm
il-6
hemoperfusion
Online Access:https://ia.tbzmed.ac.ir/PDF/ia-2-10.pdf

Internet

https://ia.tbzmed.ac.ir/PDF/ia-2-10.pdf

Similar Items